Dhru Purohit

And should we be medicalizing this situation or should we be treating it from a human level of, wow, I can imagine going through this as the most toughest thing anybody's going through.

let's get you all the support and help that's out there that doesn't come with all these downstream side effects that may not even get to the root of why you're feeling this way in the first place.

And as part of that, we've also, in America, we have a big...

We've gone through a history where a lot of people who were seeking help for mental health were stigmatized.

Not that this is unique to America.

I have a lot of friends in the UK.

This goes on in other countries as well.

And so part of that that's there is that people, even me,

are trying to be very cautious to make sure that we don't over-stigmatize.

And it's good.

It's good to be cautious.

It's good to be, you know, it's good to be aware of the different things that people are going to.

We don't want to add to the stigma, but we don't want that to prevent us from talking about the situation honestly.

And that's what we're doing today by having you on the podcast.

You're talking about the pros, the cons, and you're leaning into informed consent for everybody who's listening.

So let's talk about the standard approach when it comes to getting off of antidepressants.

And I think that the standard approach is basically you half your dose and then half it again.

And you argue that that approach is what sets people up to crash.

So what else do you want to add to the standard approach?

And can you contrast that with some of the